Alembic sells Baddi formulations plant to Scott Edil Pharmacia

By Gareth Macdonald contact

- Last updated on GMT

iStock/Radiokukka
iStock/Radiokukka

Related tags: Pharmacology

Alembic Pharmaceuticals Limited has sold its drug plant in Baddi, Himachal Pradesh to Scott Edil Pharmacia Limited.

The sale​ was announced in a Bombay Stock Exchange (BSE) filing last week. Alembic said the formulations plant was divested on a “slump sale basis​,” meaning that Chandigarh-based Scott Edil paid a lump sum.

Alembic – which generated revenue of INR31.34bn ($490m) in the 12 months ended March 31​ - also revealed the Baddi plant had made an “insignificant” contribution to its sales in fiscal 2016.

According to its website, Scott Edil Pharmacia operates a manufacturing facility and an R&D facility in Baddi.

Capacity

News of the facility sale comes a few weeks​ after Alembic inaugurated a drug manufacturing plant in Panelav, Gujarat. 

According to Alembic, the Panelav facility will supply international markets with generic drugs.

The firm also said it will cater for domestic demand at a facility it set up in Namthang, Sikkim.

A number of drug companies have set up manufacturing facilities in Sikkim​ in recent years.

In 2007, the Indian Government said manufacturers which set up in the region before April 2017 would not have to pay taxes on revenues generated by products made there for 10 consecutive years.

Alembic set its plant up in 2014 joining peers Cipla, Sun Pharma, Zydus Cadila, IPCA, Alkem Lab, Intas Pharma, Torrent Pharma and Unichem which all operate facilities in the state.

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Related suppliers

Follow us

Products

View more

Webinars